27871-89-2

Basic information

• Product Name: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester
• Synonyms: methyl 2-hydroxy-4-oxo-6-pentyl-2-cyclohexene-1-carboxylate;CYC075;2-Cyclohexene-1-carboxylic acid,2-hydroxy-4-oxo-6-pentyl-,methyl ester
• CAS NO: 27871-89-2
• Molecular Formula: C13H20O4
• Molecular Weight: 240.299
• Mol File: 27871-89-2.mol

Chemical Properties

• Boiling Point: 349.2±42.0 °C(Predicted)
• Density: 1.112±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester(27871-89-2)
• EPA Substance Registry System: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester(27871-89-2)

Safety Data

• Hazardous Substances Data: 27871-89-2(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester is used as a precursor in organic synthesis for the production of other compounds. Its complex structure and various functional groups make it a versatile building block for creating more complex molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester is used as an intermediate in the synthesis of pharmaceutical compounds. Its unique structure and functional groups can be utilized to create new drugs or improve the properties of existing ones.
Used in Chemical Manufacturing:
2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester is also used in chemical manufacturing as a raw material for the production of various chemical products. Its potential applications in this field include the synthesis of specialty chemicals, polymers, and other materials.

Upstream product

• 14309-57-0 Non-3-en-2-on 
• 108-59-8 malonic acid dimethyl ester 

Downstream Products

• 500-66-3 Olivetol 

Relevant articles and documents

BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS

The present invention provides methods for producing cannabinoids. More specifically, the invention is directed to the bio-enzymatic synthesis of THC-v, CBV and CBN by contacting a compound according to Formula I with a cannabinoid synthase enzyme. Also described is a system for producing these pharmaceutically important cannabinoids and the use of such cannabinoids as therapeutic agents.

BIOSYNTHESIS OF CANNABINOID PRODRUGS AND THEIR USE AS THERAPEUTIC AGENTS

The present invention provides methods for producing cannabinoid prodrugs. Also described are pharmaceuticals acceptable compositions of the prodrugs and a system for the large-scale production of the prodrugs.

METHODS FOR THE MANUFACTURE OF CANNABINOID PRODRUGS, PHARMACEUTICAL FORMULATIONS AND THEIR USE

Described are methods for producing cannabinoid prodrugs as well as methods for formulating such prodrugs in a pharmaceutically acceptable form and their use as therapeutic agents for treating diseases.

APPARATUS AND METHODS FOR THE SIMULTANEOUS PRODUCTION OF CANNABINOID COMPOUNDS

The present invention provides an apparatus and methods for simultaneously producing different compounds in various ratios under set conditions.

BIOSYNTHESIS OF CANNABINOIDS

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.